Prophylactic Use of Factor VIII: an Economic EvaluationRhonda L. Bohn, Louis M. Aledort, Igor Choodnovskiy et al.|Thrombosis and Haemostasis|1998Cited by 98
The economic impact of factor VIII inhibitors in patients with haemophiliaRhonda L. Bohn, Jerry Avorn, Louis M. Aledort et al.|Haemophilia|2004Cited by 55
Hemophilia Home Treatment:<i>Economic Analysis and Implications for Health Policy</i>Dennis Ross‐Degnan, Louis M. Aledort, Stephen B. Soumerai et al.|International Journal of Technology Assessment in Health Care|1995Cited by 34